Sonova H Ag Asset Resilience Ratio
Sonova H Ag asset resilience ratio. Sonova H Ag (SOON) has an Asset Resilience Ratio of 0.03% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SOON current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sonova H Ag (2005–2026)
Asset resilience ratio of Sonova H Ag from 2005 to 2026. This chart shows how Sonova H Ag's Asset Resilience Ratio has changed over time. See cash generation quality of Sonova H Ag to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Sonova H Ag's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SOON total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF0.00 | 0% |
| Short-term Investments | CHF1.90 Million | 0.03% |
| Total Liquid Assets | CHF1.90 Million | 0.03% |
Asset Resilience Insights
- Limited Liquidity: Sonova H Ag maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sonova H Ag Industry Peers by Asset Resilience Ratio
Compare Sonova H Ag's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SIEMENS HEALTH ADR/050
F:SHL1 |
Medical Devices | 1.05% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Wellell Inc
TW:4106 |
Medical Devices | 2.43% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
Sonova H Ag Asset Resilience Ratio by Year (2005–2026)
Sonova H Ag asset resilience ratio by year from 2005 to 2026. The table below shows the annual Asset Resilience Ratio data for Sonova H Ag.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 0.03% | CHF1.90 Million ≈ $2.40 Million |
CHF5.63 Billion ≈ $7.12 Billion |
-3.77pp |
| 2025-03-31 | 3.80% | CHF225.40 Million ≈ $284.97 Million |
CHF5.92 Billion ≈ $7.49 Billion |
+3.80pp |
| 2024-03-31 | 0.01% | CHF400.00K ≈ $505.71K |
CHF5.79 Billion ≈ $7.32 Billion |
-0.02pp |
| 2023-03-31 | 0.03% | CHF1.40 Million ≈ $1.77 Million |
CHF5.55 Billion ≈ $7.02 Billion |
-2.69pp |
| 2022-03-31 | 2.72% | CHF151.90 Million ≈ $192.04 Million |
CHF5.59 Billion ≈ $7.06 Billion |
-20.09pp |
| 2021-03-31 | 22.81% | CHF1.35 Billion ≈ $1.71 Billion |
CHF5.93 Billion ≈ $7.49 Billion |
+22.74pp |
| 2020-03-31 | 0.07% | CHF3.30 Million ≈ $4.17 Million |
CHF4.49 Billion ≈ $5.67 Billion |
-1.36pp |
| 2019-03-31 | 1.44% | CHF61.70 Million ≈ $78.01 Million |
CHF4.29 Billion ≈ $5.43 Billion |
-1.75pp |
| 2018-03-31 | 3.19% | CHF137.34 Million ≈ $173.63 Million |
CHF4.30 Billion ≈ $5.44 Billion |
+1.06pp |
| 2017-03-31 | 2.13% | CHF83.91 Million ≈ $106.09 Million |
CHF3.94 Billion ≈ $4.98 Billion |
+2.06pp |
| 2016-03-31 | 0.07% | CHF1.92 Million ≈ $2.42 Million |
CHF2.75 Billion ≈ $3.48 Billion |
-0.13pp |
| 2015-03-31 | 0.20% | CHF5.45 Million ≈ $6.89 Million |
CHF2.69 Billion ≈ $3.40 Billion |
+0.05pp |
| 2014-03-31 | 0.15% | CHF3.97 Million ≈ $5.02 Million |
CHF2.59 Billion ≈ $3.28 Billion |
-0.02pp |
| 2013-03-31 | 0.17% | CHF4.64 Million ≈ $5.87 Million |
CHF2.68 Billion ≈ $3.39 Billion |
-0.12pp |
| 2012-03-31 | 0.30% | CHF6.80 Million ≈ $8.60 Million |
CHF2.29 Billion ≈ $2.89 Billion |
-1.02pp |
| 2011-03-31 | 1.32% | CHF28.59 Million ≈ $36.14 Million |
CHF2.17 Billion ≈ $2.75 Billion |
+0.59pp |
| 2010-03-31 | 0.73% | CHF17.55 Million ≈ $22.19 Million |
CHF2.41 Billion ≈ $3.05 Billion |
-0.30pp |
| 2009-03-31 | 1.03% | CHF14.66 Million ≈ $18.54 Million |
CHF1.43 Billion ≈ $1.80 Billion |
-0.24pp |
| 2008-03-31 | 1.27% | CHF16.19 Million ≈ $20.47 Million |
CHF1.27 Billion ≈ $1.61 Billion |
-3.79pp |
| 2007-03-31 | 5.07% | CHF64.00 Million ≈ $80.92 Million |
CHF1.26 Billion ≈ $1.60 Billion |
+3.69pp |
| 2006-03-31 | 1.38% | CHF12.76 Million ≈ $16.13 Million |
CHF928.12 Million ≈ $1.17 Billion |
-0.29pp |
| 2005-03-31 | 1.67% | CHF12.40 Million ≈ $15.68 Million |
CHF743.36 Million ≈ $939.81 Million |
-- |
About Sonova H Ag
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service … Read more